Department of Anesthesiology, Taipei Veterans General Hospital
Taipei, 11217, Taiwan
Location status: Recruiting
NCT Number: NCT07473687
This study aims to evaluate the feasibility and accuracy of a non-contact, camera-based physiological monitoring technology in a perioperative setting (including anesthesia induction, surgery, and recovery).Conventional vital sign monitoring tools-such as ECG leads, blood pressure cuffs, and pulse oximeters-require direct skin contact, which may pose risks of cross-infection or skin injury in vulnerable populations (e.g., newborns or elderly patients). This research utilizes remote Photoplethysmography (rPPG) technology to estimate vital signs, including heart rate, blood pressure, and blood oxygen saturation (SpO2), by analyzing facial video captured via standard camera devices (Logitech C930, iPhone 16 Pro Max, and Samsung Galaxy S24 Ultra).The primary goal is to assess the consistency and stability of this non-contact system compared to clinical gold-standard monitors (Masimo Root, SedLine O3, and Radical-7) during actual surgical procedures. The findings will serve as a foundation for developing non-invasive, supplementary monitoring tools in dynamic clinical environments.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Taipei, 11217, Taiwan
Location status: Recruiting
Background and Rationale:
Perioperative vital sign monitoring is crucial for patient safety. However, current standard-of-care tools are predominantly contact-based or invasive. These devices can cause discomfort, limit patient mobility, and potentially damage fragile skin. While various non-contact sensing technologies (e.g., radar, thermal imaging) have been researched, high costs and poor adaptability to dynamic clinical settings have limited their routine use. Our team has previously validated a camera-based rPPG algorithm in clinical environments; this study seeks to further evaluate its feasibility within the rigorous conditions of an operating room (OR).
Study Objectives:
To evaluate the accuracy and consistency of a non-contact video monitoring system in measuring heart rate, blood pressure, and SpO2 across different surgical phases (pre-operative, intra-operative, and post-operative).To optimize algorithms using multi-point clinical data to enhance system robustness in dynamic surgical environments. To explore the potential of rPPG technology as a supplementary or alternative monitoring solution for patients unsuitable for traditional contact-based sensors.
Methodology:
This is a feasibility study conducted in a perioperative clinical environment. Participants will undergo simultaneous monitoring by two systems without interference with routine medical care:
Data Analysis:
The estimated physiological parameters from the non-contact software will be compared with the synchronized data from the Masimo Root system. Statistical analysis will focus on the correlation and limits of agreement between the two methods to determine the technical feasibility for future clinical translation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A non-invasive, video-based software utilizing remote Photoplethysmography (rPPG) technology to estimate heart rate, blood pressure, and SpO2 by analyzing facial video captured via camera-enabled devices.
Time frame: From anesthesia induction to recovery (approximately 2-6 hours).
The success rate of non-contact HR measurement using the rPPG software compared to the reference values from the Masimo Root clinical monitoring platform. A "success" is defined as an absolute error within +/- 3 bpm.
Unit of Measure: Percentage of successful measurements (%)
Time frame: From anesthesia induction to recovery (approximately 2-6 hours).
The success rate of non-contact SBP measurement compared to the reference values from the Masimo Root platform. A "success" is defined as an absolute error within +/- 12 mmHg.
Unit of Measure: Percentage of successful measurements (%)
Time frame: From anesthesia induction to recovery (approximately 2-6 hours).
The success rate of non-contact DBP measurement compared to the reference values from the Masimo Root platform. A "success" is defined as an absolute error within +/- 10 mmHg.
Unit of Measure: Percentage of successful measurements (%)
Time frame: From anesthesia induction to recovery (approximately 2-6 hours).
The success rate of non-contact SpO2 measurement compared to the reference values from the Masimo Root platform. A "success" is defined as an absolute error within +/- 8% (when SpO2 >/= 80%) or +/- 15% (when SpO2 < 80%).
Unit of Measure: Percentage of successful measurements (%)
Time frame: During the intraoperative phase (duration of the surgical procedure, approximately 2-6 hours).
Evaluation of the Heart Rate measurement consistency among three devices (Logitech C930, iPhone 16 Pro Max, and Samsung Galaxy S24 Ultra) compared to the Masimo Root monitor. The measurement tool is the rPPG software. Consistency will be assessed by calculating the Mean Absolute Error (MAE) of heart rate.
Unit of Measure: Beats per minute (bpm)
Time frame: During the intraoperative phase (duration of the surgical procedure, approximately 2-6 hours).
Evaluation of the Systolic and Diastolic Blood Pressure measurement consistency among three devices (Logitech C930, iPhone 16 Pro Max, and Samsung Galaxy S24 Ultra) compared to the Masimo Root monitor. The measurement tool is the rPPG software. Consistency will be assessed by calculating the Mean Absolute Error (MAE) of blood pressure.
Unit of Measure: mmHg
Contact information is provided by the study sponsor or research team.
Taipei Veterans General Hospital, Taiwan
Other Gov
Acronym: IBPM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06123117
Biliary Tract Diseases, Biliary Tract Neoplasms
Espoo, Uusimaa, Finland
View Trial DetailsNCT07363668
Biliary Tract Diseases, Cholecystitis
Erzurum, Turkey (Türkiye)
View Trial DetailsNCT07297225
Biliary Tract Diseases, Cholecystitis
Guangzhou, Guangdong, China
View Trial DetailsNCT02702843
Biliary Tract Diseases, Cholecystitis
Los Angeles, California, United States
View Trial Details